Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies Publisher Pubmed



Li Y1 ; Saul A1 ; Taylor B1 ; Ponsonby AL2 ; Simpsonyap S1, 3 ; Blizzard L1 ; Broadley S4 ; Lechnerscott J5 ; Karabudak R6 ; Patti F7, 8 ; Eichau S9 ; Onofrj M10 ; Ozakbas S11 ; Horakova D12 Show All Authors
Authors
  1. Li Y1
  2. Saul A1
  3. Taylor B1
  4. Ponsonby AL2
  5. Simpsonyap S1, 3
  6. Blizzard L1
  7. Broadley S4
  8. Lechnerscott J5
  9. Karabudak R6
  10. Patti F7, 8
  11. Eichau S9
  12. Onofrj M10
  13. Ozakbas S11
  14. Horakova D12
  15. Kubala Havrdova E12
  16. Grandmaison F13
  17. Alroughani R14
  18. Gerlach O15, 16
  19. Amato MP17
  20. Altintas A18
  21. Girard M19
  22. Duquette P19
  23. Blanco Y20
  24. Ramotello C21
  25. Laureys G22
  26. Kalincik T23, 24
  27. Khoury SJ25
  28. Shaygannejad V26
  29. Etemadifar M27
  30. Singhal B28
  31. Mrabet S29, 30
  32. Foschi M31, 32
  33. Habek M33, 34
  34. John N35, 36
  35. Hughes S37
  36. Mccombe P38, 39
  37. Ampapa R40
  38. Van Der Walt A41, 42
  39. Butzkueven H43
  40. De Gans K44
  41. Mcguigan C45, 46
  42. Orejaguevara C47
  43. Sa MJ48, 49
  44. Petersen T50
  45. Alharbi T51
  46. Sempere AP52
  47. Van Wijmeersch B53
  48. Grigoriadis N54
  49. Prevost J55
  50. Gray O56
  51. Castillotrivino T57
  52. Macdonell R58, 59, 60
  53. Lugaresi A61, 62
  54. Sajedi SA63
  55. Van Der Mei I1

Source: Journal of Neurology Published:2024


Abstract

It is unknown whether the currently known risk factors of multiple sclerosis reflect the etiology of progressive-onset multiple sclerosis (POMS) as observational studies rarely included analysis by type of onset. We designed a case–control study to examine associations between environmental factors and POMS and compared effect sizes to relapse-onset MS (ROMS), which will offer insights into the etiology of POMS and potentially contribute to prevention and intervention practice. This study utilizes data from the Primary Progressive Multiple Sclerosis (PPMS) Study and the Australian Multi-center Study of Environment and Immune Function (the AusImmune Study). This report outlines the conduct of the PPMS Study, whether the POMS sample is representative, and the planned analysis methods. The study includes 155 POMS, 204 ROMS, and 558 controls. The distributions of the POMS were largely similar to Australian POMS patients in the MSBase Study, with 54.8% female, 85.8% POMS born before 1970, mean age of onset of 41.44 ± 8.38 years old, and 67.1% living between 28.9 and 39.4° S. The POMS were representative of the Australian POMS population. There are some differences between POMS and ROMS/controls (mean age at interview: POMS 55 years vs. controls 40 years; sex: POMS 53% female vs. controls 78% female; location of residence: 14.3% of POMS at a latitude ≤ 28.9°S vs. 32.8% in controls), which will be taken into account in the analysis. We discuss the methodological issues considered in the study design, including prevalence-incidence bias, cohort effects, interview bias and recall bias, and present strategies to account for it. Associations between exposures of interest and POMS/ROMS will be presented in subsequent publications. © The Author(s) 2023.
Other Related Docs
15. Comparison of Fingolimod, Dimethyl Fumarate and Teriflunomide for Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2019)
19. Disability Accrual in Primary and Secondary Progressive Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2023)